The Klöckner Pentaplast Group announces plans to expand its high-barrier film lamination and coating capacities to reinforce the company’s commitment to the global pharmaceutical and medical industries.
Beginning in early 2017, Klöckner Pentaplast (kp) will use a state-of-the-art system to produce Aclar laminated pharmaceutical films from its site in Montabaur, Germany, a trusted source of high quality kp films for many industries. The new Montabaur line will be fully operational for the entire kp Pentapharm Aclar product range by the end of 2017.
As a result of this investment, the Klöckner Pentaplast facility in Bern, Switzerland, will also have added capacity available to produce PVdC-coated high-barrier pharmaceutical films, while continuing to be a backup site for Aclar lamination. The plan strengthens kp’s dedication to its global packaging customers by providing improved customer service and security of supply from multiple sites under a global DMF.
“This capacity expansion is part of Klöckner Pentaplast’s long-term strategy to leverage our global footprint to maximize improvements across the value chain, with a focus on being even more responsive to our pharmaceutical customers’ needs now and in the future,“ says Markus Pischulti, Business Director, Pharmaceutical Films EMEA.
